Search Results - "Kamishohara, Masaru"
-
1
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth
Published in Molecular cancer therapeutics (01-12-2004)“…Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 play a central role in angiogenesis, which is necessary for solid tumors to expand and…”
Get full text
Journal Article -
2
Is Lymphoid Leukemia Less Susceptible to Busulfan Than Myeloid Leukemia? Comparison of Cytotoxicities of Busulfan, Melphalan, Fludarabine, Clofarabine, Cytosine Arabinoside, and Etoposide in Human Myeloid and Lymphoid Leukemia Cell Lines
Published in Biology of blood and marrow transplantation (01-02-2015)Get full text
Journal Article -
3
Selective Accumulation of the Endoplasmic Reticulum–Golgi Intermediate Compartment Induced by the Antitumor Drug KRN5500
Published in Experimental cell research (01-05-2000)“…KRN5500 is a semisynthetic spicamycin analogue consisting of a seven-carbon amino sugar linked to a C14 unsaturated fatty acid through glycine and to the amino…”
Get full text
Journal Article -
4
Vicenistatin, a novel 20-membered macrocyclic lactam antitumor antibiotic
Published in Journal of antibiotics (1993)“…A new antitumor antibiotic vicenistatin was isolated from the culture broth of Streptomyces sp. HC34. The structure of vicenistatin was elucidated by NMR…”
Get more information
Journal Article -
5
Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice
Published in The Journal of immunology (1950) (01-06-2001)“…The role of mouse liver NK1.1 Ag(+) T (NKT) cells in the antitumor effect of alpha-galactosylceramide (alpha-GalCer) has been unclear. We now show that,…”
Get full text
Journal Article -
6
The Molecular Interaction of Fas and FAP-1
Published in The Journal of biological chemistry (28-03-1997)“…Fas (APO-1/CD95), which is a member of the tumor necrosis factor receptor superfamily, is a cell surface receptor that induces apoptosis. A protein tyrosine…”
Get full text
Journal Article -
7
Structure-antitumor activity relationship of semi-synthetic spicamycin analogues
Published in Journal of antibiotics (1993)“…Spicamycin, a nucleoside antibiotic containing fatty acids with a variety of chain lengths (C12-C18), showed potent antitumor activity against human gastric…”
Get more information
Journal Article -
8
-
9
Structure-antitumor activity relationship of semi-synthetic Spicamycin derivatives
Published in Journal of antibiotics (1995)“…New derivatives of spicamycin modified at the fatty acid moieties of the molecule were synthesized and their structure-activity relationships were examined…”
Get more information
Journal Article -
10
Antitumor activity of SPM VIII, a derivative of the nucleoside antibiotic spicamycin, against human tumor xenografts
Published in Journal of antibiotics (1994)“…The antitumor activity of spicamycin analogue SPM VIII against human stomach, breast, lung, colon and esophageal cancers was compared to that of mitomycin C…”
Get more information
Journal Article -
11
Synthesis and antitumor activities of glycine-exchanged analogs of spicamycin
Published in Journal of antibiotics (1995)“…A series of SPM VIII analogs were synthesized to investigate the effect of the amino acid moiety on the antitumor activity. The L-threonine analog and the…”
Get more information
Journal Article -
12
The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis
Published in The Journal of biological chemistry (28-03-1997)“…Fas (APO-1/CD95), which is a member of the tumor necrosis factor receptor superfamily, is a cell surface receptor that induces apoptosis. A protein tyrosine…”
Get full text
Journal Article -
13
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies
Published in Biology of blood and marrow transplantation (01-08-2016)“…Abstract Busulfan (Bu)-containing regimens are commonly used in myeloablative conditioning regimens before allogeneic hematopoietic cell transplantation (HCT)…”
Get full text
Journal Article -
14
Structural Modification of Fas C-Terminal Tripeptide and Its Effects on the Inhibitory Activity of Fas/FAP-1 Binding
Published in Journal of medicinal chemistry (26-08-1999)“…We report the structural requirements of the C-terminal tripeptide derivative of Fas (Ac-Ser-Leu-Val-OH, 1) for the inhibitory activity of Fas/FAP-1 binding…”
Get full text
Journal Article -
15
Inhibitory effect of a spicamycin derivative, KRN5500, on the growth of hepatic metastasis of human colon cancer-producing tissue polypeptide antigen
Published in Cancer chemotherapy and pharmacology (1996)“…The inhibitory effect of KRN5500, a spicamycin derivative, on the growth of hepatic metastasis of the tissue polypeptide antigen (TPA)-producing human colon…”
Get full text
Journal Article -
16
Antitumor activity of a spicamycin derivative, KRN5500, and its active metabolite in tumor cells
Published in Oncology research (1994)“…KRN5500, (6-[4-Deoxy-4-(2E,4E)-tetradecadienoylglycyl]amino-L-glycero - beta-L-mannoheptopyranosyl]amino-9H-purine), was semi-synthesized in an attempt to…”
Get more information
Journal Article -
17
Mechanisms of the Antimetastatic Effect in the Liver and of the Hepatocyte Injury Induced by {{alpha}}-Galactosylceramide in Mice
Published in The Journal of immunology (1950) (01-06-2001)Get full text
Journal Article